SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity

ByThe Short Paper

Article

967 subjects were tested for IgG antibodies against COVID-19. They multiple subgroups of suspected cases, healthy donors, patients with rheumatic disease, and patients positive for polymerase chain reaction. They found PCR and IgG were in agreement in 83% of samples.  The levels of IgG and IgM levels were measured and found to not associate with mild and severe disease course.

TL;DR Antibody levels against COVID-19 does not predict clinical severity

Similar Posts

Simple Summary – Transfusion Volume for Children with Severe Anemia in Africa

ByThe Short Paper

Link to the article: https://www.nejm.org/doi/full/10.1056/NEJMoa1900100?query=featured_home Similar to the last article, it’s been known that the WHO has specific transfusion guidelines which parts of Africa follows. In patients with severe anemia, red blood cells are transfused at a flat rate of 20 ml per kilogram of body weight. Although this transfusion rate is not in line with…

A Multifactorial Approach to Overuse Running Injuries: A 1-Year Prospective Study

ByThe Short Paper

Article The prospective study looked at 76 runners, males and females. They kept a running diary for 1 year and were monitored injuries during this time period.   They found injured males tended to be heavier, had greater weekly distances, and greater side to side acceleration. Injured females tended to be heavier, longer flight times, and…

Metformin improves boar sperm quality via 5′-AMP-activated protein kinase-mediated energy metabolism in vitro

ByThe Short Paper

Article Sperm requires ATP to function. The study decided to see if metformin, which activates 5′-AMP-activated protein kinase, would improve sperm function, specifically in boars. They found that metformin treated sperm had improvement in “sperm motility parameters, mitochondrial membrane potential, ATP content, p-AMPK, glucose uptake, and lactate efflux.” TL;DR Metformin (typically a diabetic medication) improves…

Single-Dose Psilocybin Treatment for Major Depressive Disorder

ByThe Short Paper

One-time psilocybin treatment for depression A study investigated the effectiveness and safety of psilocybin, a compound found in certain mushrooms, for treating major depressive disorder. In a controlled trial with 104 adults, a 25-mg dose of psilocybin, when combined with psychological support, resulted in a significant and enduring improvement in depressive symptoms compared to a…

The Development of Personalized Depression Treatment Using Brain Signals and AI with Deep Brain Stimulation

ByThe Short Paper

Cingulate dynamics track depression recovery with deep brain stimulation Deep brain stimulation (DBS) can help people with severe depression when other treatments don’t work, but it’s hard to figure out how to adjust it for each person. Scientists have developed a way to record brain signals and use artificial intelligence to find out when the…

Antibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux

ByThe Short Paper

This study looked at the use of continuous antibiotic treatment to prevent urinary tract infections (UTIs) in infants with severe vesicoureteral reflux (a condition where urine flows back from the bladder to the kidneys). The study involved infants aged 1 to 5 months who had not had a UTI before. The results showed that those…